Epigenetic reprogramming of primary pancreatic cancer cells counteracts their in vivo tumourigenicity

04:58 EDT 16 Jul 2019 | Nature Publishing

More From BioPortfolio on "Epigenetic reprogramming of primary pancreatic cancer cells counteracts their in vivo tumourigenicity"